Author/Creator: Nurmohamed, M T - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Nurmohamed, M T

1. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. Issue 8 (15th July 2009)

Authors:: van den Bemt, B J F; Vos, K; Broeder, A A den; Blom, M; Thurlings, R M; Bartelds, G M; Stapel, S O; Barrera, P; Tak, P P; Nurmohamed, M T; Wolbink, G-J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 68:Issue 8(2009)
Page Start:: 1368
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. A1.77 Interferon regulatory factor 5 (IRF5) gene variant RS2004640 is associated with carotid intima media thickness in rheumatoid arthritis patients. (31st January 2014)

Authors:: Vosslamber, S; van Sijl, A; Bos, C L; Lubbers, J; de Ridder, S; Voskuyl, A E; Nurmohamed, M T; Verweij, C L
Journal:: Annals of the rheumatic diseases
Issue:: Volume 73:Supplement 1(2014)
Page Start:: A34
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice. Issue 4 (15th March 2005)

Authors:: Neven, N; Vis, M; Voskuyl, A E; Wolbink, G J; Nurmohamed, M T; Dijkmans, B A C; Lems, W F
Journal:: Annals of the rheumatic diseases
Issue:: Volume 64:Issue 4(2005)
Page Start:: 645
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Ankylosing spondylitis: a risk factor for myocardial infarction?. Issue 3 (28th April 2009)

Authors:: Peters, M J L; Visman, I; Nielen, M M J; Van Dillen, N; Verheij, R A; van der Horst-Bruinsma, I E; Dijkmans, B A C; Nurmohamed, M T
Journal:: Annals of the rheumatic diseases
Issue:: Volume 69:Issue 3(2010)
Page Start:: 579
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study. Issue 5 (5th July 2009)

Authors:: Bartelds, G M; Wijbrandts, C A; Nurmohamed, M T; Stapel, S; Lems, W F; Aarden, L; Dijkmans, B A C; Tak, P P; Wolbink, G J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 69:Issue 5(2010)
Page Start:: 817
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis. Issue 5 (25th October 2005)

Authors:: van Halm, V P; Slot, M C; Nurmohamed, M T; Cohen Tervaert, J W; Dijkmans, B A C; Voskuyl, A E
Journal:: Annals of the rheumatic diseases
Issue:: Volume 65:Issue 5(2006)
Page Start:: 590
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders. Issue 10 (17th February 2016)

Authors:: Agca, R; Heslinga, S C; van Halm, V P; Nurmohamed, M T
Journal:: Heart
Issue:: Volume 102:Issue 10(2016)
Page Start:: 790
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study. Issue 11 (24th May 2010)

Authors:: Jamnitski, A; Visman, I M; Peters, M J L; Dijkmans, B A C; Voskuyl, A E; Nurmohamed, M T
Journal:: Annals of the rheumatic diseases
Issue:: Volume 69:Issue 11(2010)
Page Start:: 1929
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis. Issue 7 (21st February 2007)

Authors:: Peters, M J L; Vis, M; van Halm, V P; Wolbink, G J; Voskuyl, A E; Lems, W F; Dijkmans, B A C; Twisk, J W R; de Koning, M H M T; van de Stadt, R J; Nurmohamed, M T
Journal:: Annals of the rheumatic diseases
Issue:: Volume 66:Issue 7(2007)
Page Start:: 958
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Issue 7 (16th November 2009)

Authors:: van Eijk, I C; Tushuizen, M E; Sturk, A; Dijkmans, B A C; Boers, M; Voskuyl, A E; Diamant, M; Wolbink, G J; Nieuwland, R; Nurmohamed, M T
Journal:: Annals of the rheumatic diseases
Issue:: Volume 69:Issue 7(2010)
Page Start:: 1378
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗